Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Sawada

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1983
[Malignant lymphoma--recent progress in diagnosis and treatment. 3. Progress in therapeutic results. (1). Multidisciplinary approach to patients with malignant lymphoma]U Sawada
Japanese Journal of Medicine|February 1, 1984
Progress in therapeutic results. A multidisciplinary approach to patients with malignant lymphomaU Sawada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1993
[Treatment of high risk non-Hodgkin's lymphoma]U Sawada
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[Non-Hodgkin lymphoma]U Sawada
Experimental Hematology|July 1, 1980
In vitro hemopoiesis of W/WV and +/+ marrow cells cultured alone and with thymocytesU Sawada, S S Adler
Blut|January 1, 1981
In vitro interactions between thymocytes and hemopoietic precursor cellsU Sawada, S S Adler
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2000
[Treatment of intermediate and high grade non-Hodgkin's lymphoma]T Yamazaki, Y Kura, U Sawada
Ryoikibetsu Shokogun Shirizu|December 16, 1998
[Cutaneous pseudolymphoma]Y Kura, U Sawada, T Ochiai
The Journal of International Medical Research|April 12, 2006
Durable molecular complete remission induced by low-dose imatinib plus low-dose interferon alpha in a patient with chronic myelogenous leukaemiaJ Takeuchi, K Miura, Y Hatta, et al.
Scandinavian Journal of Haematology|August 1, 1979
Effect of human serum from patients with haematological disorders on mouse pluripotent haemopoietic stem cells (CFU-S)U Sawada, R D Kuznetsky, S S Adler
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1983
[Malignant lymphoma--recent progress in diagnosis and treatment. 3. Progress in therapeutic results. (1). Multidisciplinary approach to patients with malignant lymphoma]U Sawada
Japanese Journal of Medicine|February 1, 1984
Progress in therapeutic results. A multidisciplinary approach to patients with malignant lymphomaU Sawada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1993
[Treatment of high risk non-Hodgkin's lymphoma]U Sawada
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[Non-Hodgkin lymphoma]U Sawada
Experimental Hematology|July 1, 1980
In vitro hemopoiesis of W/WV and +/+ marrow cells cultured alone and with thymocytesU Sawada, S S Adler
Blut|January 1, 1981
In vitro interactions between thymocytes and hemopoietic precursor cellsU Sawada, S S Adler
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2000
[Treatment of intermediate and high grade non-Hodgkin's lymphoma]T Yamazaki, Y Kura, U Sawada
Ryoikibetsu Shokogun Shirizu|December 16, 1998
[Cutaneous pseudolymphoma]Y Kura, U Sawada, T Ochiai
The Journal of International Medical Research|April 12, 2006
Durable molecular complete remission induced by low-dose imatinib plus low-dose interferon alpha in a patient with chronic myelogenous leukaemiaJ Takeuchi, K Miura, Y Hatta, et al.
Scandinavian Journal of Haematology|August 1, 1979
Effect of human serum from patients with haematological disorders on mouse pluripotent haemopoietic stem cells (CFU-S)U Sawada, R D Kuznetsky, S S Adler
Pageof 8